Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.597ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.597ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.177EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.177EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.177ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.177ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.177EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.177EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.177ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.177ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.301EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.301EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.301ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.301ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.301EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.301EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.301ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.301ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.308EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.308EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.308ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.308ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.308EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.308EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.308ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.308ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.210EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.210EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.210ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.210ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.210EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.210EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.210ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.210ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.325EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.325EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.325ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.325ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.325EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.325EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.325ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.325ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.44ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.44ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.44EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.44EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used